CIK 0000907654 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 0 | 0 | 0 | |
| Net income (USD) | -9.9 M | -19.3 M | -9.7 M | |
| Diluted EPS (USD/shares) | -3.87 | -0.37 | -1.39 |
Forms on file (last 1,000): 4 257, 8-K 249, 10-Q 52, SC 13G/A 47, 424B4 46, 3 41, 424B5 24, SC 13G 23. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ORKA (0.002 USD), /gw/filings/filings?ticker=ORKA&form=8-K, /gw/filings/facts?ticker=ORKA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange